logo

For the Inventor, By the Inventor

Calgary, Canada

Synsorb Biotech, Inc.

Calculating rank
USPTO Granted Patents = 34


Forward Citations = 123

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Glen D Armstrong (20 out of 38 patents)

silverMedal Louis D Heerze (13 out of 21 patents)

bronzeMedal Ole Hindsgaul (11 out of 29 patents)

4.  Bradley G Thompson (3 out of 151 patents)

5.  David J Rafter (3 out of 3 patents)

6.  Robert M Ratcliffe (3 out of 11 patents)

7.  Ulf Nilsson (2 out of 21 patents)

8.  Keiko Sujino (2 out of 16 patents)

9.  David C Schriemer (2 out of 14 patents)

10.  Monica Marija Palcic (2 out of 5 patents)

11.  Francois Auclair (2 out of 2 patents)

12.  Hermy Lior (2 out of 2 patents)

13.  George A Wells (2 out of 2 patents)

14.  Andrew M MacKenzie (2 out of 2 patents)

15.  Paul R Goodyer (2 out of 2 patents)


Core Competencies:
Sialylated Oligosaccharides
C. Difficile
Bacterial Dysentery
Toxin Binding
Mass Spectrometry
Thio-Oligosaccharides
Galactose Derivatives
Combinatorial Synthesis
Cholera Treatment
Solid Support Matrices
Toxin Removal
Carbohydrate Libraries

34 patents:

1. 6528274 - Method for the production of sialylated oligosaccharides (2003-03-04),
2. 6465435 - Treatment of C. difficile toxin B associated conditions (2002-10-15),
3. 6358930 - Treatment of C. difficile toxin B associated conditions (2002-03-19),
4. 6224891 - Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions (2001-05-01),
5. 6194178 - Method for the production of sialylated oligosaccharides (2001-02-27),
6. 6191418 - Device for delivery of multiple liquid sample streams to a mass spectrometer (2001-02-20),
7. 6177553 - Solid phase synthesis of thio-oligosaccharides (2001-01-23),
8. 6174867 - 1-galactose derivatives having a carbon- or nitrogen-containing aglycon linkage (2001-01-16),
9. 6121242 - Treatment of bacterial dysentery (2000-09-19),
10. 6107282 - Treatment of C. difficile toxin B associated conditions (2000-08-22),
11. 6087339 - Saccharide derivatives (2000-07-11),
12. 6069137 - Treatment of traveller's diarrhea (2000-05-30),
13. 6063769 - 1-thiogalactose derivatives (2000-05-16),
14. 6054047 - Apparatus for screening compound libraries (2000-04-25),
15. 6013635 - Treatment of C. difficile toxin B associated conditions (2000-01-11),
Company Overview
Synsorb Biotech, Inc. is a biotechnology company based in Calgary, Canada, specializing in the development of innovative therapeutic solutions. The organization focuses on addressing unmet medical needs through its expertise in biopharmaceuticals and advanced drug delivery systems. With a commitment to research and development, Synsorb aims to create effective treatments that enhance patient outcomes, leveraging cutting-edge technology in the biotechnological landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

34 Patents

#22 in Calgary

#399 in Canada

#19,664 in the World

Calgary, CA
Calgary, Canada

Synsorb Biotech, Inc.

Forward Citations = 123

25 inventors:

goldMedal Glen D Armstrong (20 out of 38 patents)

silverMedal Louis D Heerze (13 out of 21 patents)

bronzeMedal Ole Hindsgaul (11 out of 29 patents)

4.  Bradley G Thompson (3 out of 151 patents)

5.  David J Rafter (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synsorb Biotech, Inc.. Retrieved from https://idiyas.com/company/synsorb-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…